IFNAR1 and infection: To determine whether infection with TC83 or TC83/E1ID-syn led to differential activation of type-I IFN responses, Raw264.7 were treated with antibodies specific for the IFN-alpha receptor (IFNAR) or an IgG isotype control antibody prior to and during infection (Fig. 3E).